BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lees C, Godin J, McElhaney JE, McNeil SA, Loeb M, Hatchette TF, LeBlanc J, Bowie W, Boivin G, McGeer A, Poirier A, Powis J, Semret M, Webster D, Andrew MK. Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults. J Infect Dis 2020;222:428-37. [PMID: 32147711 DOI: 10.1093/infdis/jiaa092] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Lv C, Shi W, Pan T, Li H, Peng W, Xu J, Deng J. Exploration of Aging-Care Parameters to Predict Mortality of Patients Aged 80-Years and Above with Community-Acquired Pneumonia. Clin Interv Aging 2022;17:1379-91. [PMID: 36164658 DOI: 10.2147/CIA.S382347] [Reference Citation Analysis]
2 Branche AR, Saiman L, Walsh EE, Falsey AR, Jia H, Barrett A, Alba L, Phillips M, Finelli L. Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults. Influenza Other Respir Viruses 2022. [PMID: 36069297 DOI: 10.1111/irv.13043] [Reference Citation Analysis]
3 Gärtner BC, Weinke T, Wahle K, Kwetkat A, Beier D, Schmidt KJ, Schwarz TF. Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective - A systematic review of recently published literature on real-world data. Vaccine 2022:S0264-410X(22)00440-6. [PMID: 35459556 DOI: 10.1016/j.vaccine.2022.04.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Herring WL, Zhang Y, Shinde V, Stoddard J, Talbird SE, Rosen B. Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States. Vaccine 2021:S0264-410X(21)01609-1. [PMID: 34933763 DOI: 10.1016/j.vaccine.2021.12.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Patel MM, York IA, Monto AS, Thompson MG, Fry AM. Immune-mediated attenuation of influenza illness after infection: opportunities and challenges. The Lancet Microbe 2021;2:e715-25. [DOI: 10.1016/s2666-5247(21)00180-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Adams K, Tenforde MW, Chodisetty S, Lee B, Chow EJ, Self WH, Patel MM. A literature review of severity scores for adults with influenza or community-acquired pneumonia - implications for influenza vaccines and therapeutics. Hum Vaccin Immunother 2021;:1-15. [PMID: 34757894 DOI: 10.1080/21645515.2021.1990649] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Goldman CR, Sieling WD, Alba LR, Silverio Francisco RA, Vargas CY, Barrett AE, Phillips M, Finelli L, Saiman L. Severe Clinical Outcomes Among Adults Hospitalized With Respiratory Syncytial Virus Infections, New York City, 2017-2019. Public Health Rep 2021;:333549211041545. [PMID: 34487436 DOI: 10.1177/00333549211041545] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Hussien H, Nastasa A, Apetrii M, Nistor I, Petrovic M, Covic A. Different aspects of frailty and COVID-19: points to consider in the current pandemic and future ones. BMC Geriatr 2021;21:389. [PMID: 34176479 DOI: 10.1186/s12877-021-02316-5] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
9 Barazzoni R, Bischoff SC, Busetto L, Cederholm T, Chourdakis M, Cuerda C, Delzenne N, Genton L, Schneider S, Singer P, Boirie Y; endorsed by the ESPEN Council. Nutritional management of individuals with obesity and COVID-19: ESPEN expert statements and practical guidance. Clin Nutr 2021:S0261-5614(21)00248-X. [PMID: 34140163 DOI: 10.1016/j.clnu.2021.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
10 Zucchelli A, Bologna E, Marengoni A. Why data on frailty and SARS-CoV-2 infection are basic to progress. Aging Clin Exp Res 2021;33:1429-32. [PMID: 33797742 DOI: 10.1007/s40520-021-01846-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Andrew MK, Schmader KE, Rockwood K, Clarke B, McElhaney JE. Considering Frailty in SARS-CoV-2 Vaccine Development: How Geriatricians Can Assist. Clin Interv Aging 2021;16:731-8. [PMID: 33953551 DOI: 10.2147/CIA.S295522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Iwai-Saito K, Shobugawa Y, Aida J, Kondo K. Frailty is associated with susceptibility and severity of pneumonia in older adults (A JAGES multilevel cross-sectional study). Sci Rep 2021;11:7966. [PMID: 33846416 DOI: 10.1038/s41598-021-86854-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Marengoni A, Zucchelli A, Vetrano DL, Armellini A, Botteri E, Nicosia F, Romanelli G, Beindorf EA, Giansiracusa P, Garrafa E, Ferrucci L, Fratiglioni L, Bernabei R, Onder G. Beyond Chronological Age: Frailty and Multimorbidity Predict In-Hospital Mortality in Patients With Coronavirus Disease 2019. J Gerontol A Biol Sci Med Sci 2021;76:e38-45. [PMID: 33216846 DOI: 10.1093/gerona/glaa291] [Cited by in Crossref: 19] [Cited by in F6Publishing: 32] [Article Influence: 19.0] [Reference Citation Analysis]
14 Swain SL, Kugler-Umana O, Tonkonogy S. "An Intrinsic Program Determines Key Age-Associated Changes in Adaptive Immunity that Limit Response to Non-Pathogens.". Front Aging 2021;2:701900. [PMID: 35382063 DOI: 10.3389/fragi.2021.701900] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Aw D, Woodrow L, Ogliari G, Harwood R. Association of frailty with mortality in older inpatients with Covid-19: a cohort study. Age Ageing 2020;49:915-22. [PMID: 32778870 DOI: 10.1093/ageing/afaa184] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 31.5] [Reference Citation Analysis]
16 Andrew MK, McNeil SA. Influenza vaccination and the evolution of evidence-based recommendations for older adults: A Canadian perspective. Vaccine 2021;39 Suppl 1:A36-41. [PMID: 32958335 DOI: 10.1016/j.vaccine.2020.09.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]